---
title: "TBPH: Definitive acquisition agreement, strong YUPELRI® growth, and major cost reductions in Q2 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295409943.md"
description: "Entered a definitive agreement to be acquired by Zymeworks, with strong YUPELRI® sales growth and significant cost reductions. Q2 2026 saw an 11% revenue increase year-over-year, a net loss due to prior year one-time gains, and a robust cash position with no debt.Original document: Theravance Biopharma, Inc. [TBPH] SEC 8-K Current Report — Aug. 10 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-10T12:49:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295409943.md)
  - [en](https://longbridge.com/en/news/295409943.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295409943.md)
generator: "portal-rs"
---

# TBPH: Definitive acquisition agreement, strong YUPELRI® growth, and major cost reductions in Q2 2026

Entered a definitive agreement to be acquired by Zymeworks, with strong YUPELRI® sales growth and significant cost reductions. Q2 2026 saw an 11% revenue increase year-over-year, a net loss due to prior year one-time gains, and a robust cash position with no debt.

Original document: Theravance Biopharma, Inc. \[TBPH\] SEC 8-K Current Report — Aug. 10 2026

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [TBPH.US](https://longbridge.com/en/quote/TBPH.US.md)
- [ZYME.US](https://longbridge.com/en/quote/ZYME.US.md)

## Related News & Research

- [Theravance Biopharma reports CYPRESS Phase 3 miss but FDA grants Type C meeting to discuss future trial](https://longbridge.com/en/news/296955575.md)
- [HC Wainwright Has Strong Estimate for Zymeworks Q3 Earnings](https://longbridge.com/en/news/297164512.md)
- [iShares Core S&P 500 ETF declares Q3 2026 distribution of R$ 0.10 per unit](https://longbridge.com/en/news/297548335.md)
- [Gaming and Leisure Properties declares Q3 2026 dividend of $0.82 per share](https://longbridge.com/en/news/297652371.md)
- [Jefferies declares Q3 2026 distribution of R$ 1.4 per unit, payable Sept. 3](https://longbridge.com/en/news/297683771.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**